Gene Therapy Breakthrough: uniQure’s QURE Stock Skyrockets on Huntington’s Triumph
Stock Performance and Valuation Metrics uniQure’s stock performance in 2025 has been remarkably strong, capped by the explosive move on Sep. 24 after the Huntington’s data release. Prior to the announcement, QURE was